Holista Colltech Limited (AU:HCT)
ASX:HCT
Want to see AU:HCT full AI Analyst Report?
HCT Stock Chart & Stats
AU$0.09
<AU$0.01(10.00%)
At close: 4:00 PM EST
AU$0.09
<AU$0.01(10.00%)
Day’s Range― - ―
52-Week RangeAU$0.04 - AU$0.11
Previous CloseN/A
Volume829.52K
Average Volume (3M)72.05K
Market Cap
AU$25.75M
Enterprise ValueAU$18.37M
Total Cash (Recent Filing)AU$2.16M
Total Debt (Recent Filing)AU$1.59M
Price to Earnings (P/E)―
Beta0.32
Next Earnings
Aug 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding367,834,350
10 Day Avg. Volume123,924
30 Day Avg. Volume72,050
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)28.04
Price to Sales (P/S)5.45
P/FCF Ratio-20.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Diversified Revenue StreamsMultiple commercial channels (finished products, ingredient supply, contract manufacturing and licensing) create durable optionality. This reduces single-customer concentration, allows revenue capture at different margin points and supports resilience as product adoption or channels evolve over months.
R&D And Proprietary FormulationsAn R&D-focused model with proprietary formulations supports product differentiation and potential licensing income. Over a multi-month horizon, owned IP can enable higher gross margins, repeatable product launches and partnerships that sustain revenue beyond short-term demand swings.
Balance Sheet Improved To Positive EquityRestoring positive equity signals an improvement in solvency versus recent years, which can materially reduce immediate default risk and improve access to non-dilutive financing. That structural repair, if maintained, gives the company a firmer footing to execute strategic plans.
Bears Say
Persistent Negative Cash GenerationConsistent negative operating and free cash flow indicate ongoing cash burn and limited internal funding for growth or working capital. Over several months this forces reliance on external financing, increasing dilution or debt and constraining the company's ability to scale or absorb shocks.
Sharp Revenue Contraction And Volatile MarginsLarge, recent revenue declines and swings in gross/net margins reflect weak demand or disrupted product economics. Such volatility undermines forecasting, hinders reinvestment planning and raises risk that margins cannot sustainably recover without structural product or distribution improvements.
Elevated Leverage And Tiny Operating ScaleHigh debt relative to equity combined with a minimal workforce constrains operational flexibility and execution capacity. Over the medium term, leverage amplifies refinancing risk while the small team limits commercialization scale, making growth execution and cost control more difficult.
Holista Colltech Limited News
HCT FAQ
What was Holista Colltech Limited’s price range in the past 12 months?
Holista Colltech Limited lowest share price was AU$0.04 and its highest was AU$0.11 in the past 12 months.
What is Holista Colltech Limited’s market cap?
Holista Colltech Limited’s market cap is AU$25.75M.
When is Holista Colltech Limited’s upcoming earnings report date?
Holista Colltech Limited’s upcoming earnings report date is Aug 28, 2026 which is in 105 days.
How were Holista Colltech Limited’s earnings last quarter?
Holista Colltech Limited released its earnings results on Jan 29, 2026. The company reported -AU$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.002.
Is Holista Colltech Limited overvalued?
According to Wall Street analysts Holista Colltech Limited’s price is currently Overvalued.
Does Holista Colltech Limited pay dividends?
Holista Colltech Limited does not currently pay dividends.
What is Holista Colltech Limited’s EPS estimate?
Holista Colltech Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Holista Colltech Limited have?
Holista Colltech Limited has 367,834,350 shares outstanding.
What happened to Holista Colltech Limited’s price movement after its last earnings report?
Holista Colltech Limited reported an EPS of -AU$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Holista Colltech Limited?
Currently, no hedge funds are holding shares in AU:HCT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Holista Colltech Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
212.00%
12-Months-Change
Fundamentals
Return on Equity
-321.20%
Trailing 12-Months
Asset Growth
72.50%
Trailing 12-Months
Company Description
Holista Colltech Limited
Holista CollTech Limited operates as a biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection control Solutions, and Food Ingredients segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; and healthy food ingredients, including low-glycaemic index (GI) flour mix for noodles, pasta, flatbreads and other baked products, low-sodium salt, low-fat fried foods, less-calorie sugar, and low-GI sugar. The company also provides infection control solutions. Holista CollTech Limited is based in Subiaco, Australia.
Technical Analysis
Wellnex Life Ltd
―
EVE Health Group Limited
―
―
Forbidden Foods Ltd
―
Maggie Beer Holdings Ltd.
―